StockWatch
·
Pharmaceutical Preparations
Quarterly ResultJun 1, 2026, 04:05 PM

Polomar Health Services Reports Q1 Revenue of $1.01M, Narrowed Net Loss

AI Summary

Polomar Health Services, Inc. (PMHS) filed its Form 10-Q for the period ending March 31, 2026. The company reported a significant increase in revenue to $1,005,519 from $4,542 in the prior year, leading to a narrowed net loss of $25,377 compared to $456,855 in the same period last year. Despite the improved operational performance, the company's total liabilities exceeded its total assets, resulting in a substantial stockholders' deficit. The filing also details various corporate actions, loan agreements, and business developments, including the planned launch of the SlimRx online platform and ongoing discussions with marketing partners.

Key Highlights

  • Polomar Health Services reported revenue of $1,005,519 for the three months ended March 31, 2026, a significant increase from $4,542 in the prior year period.
  • Gross profit surged to $550,489 for Q1 2026, compared to $3,182 in Q1 2025.
  • Net loss narrowed to $25,377 for Q1 2026, a substantial improvement from a net loss of $456,855 in Q1 2025.
  • Basic and diluted net loss per common share was ($0.00) for Q1 2026, compared to ($0.02) for Q1 2025.
  • Total assets increased to $516,600 as of March 31, 2026, from $390,043 as of December 31, 2025.
  • Total liabilities increased to $1,762,118 as of March 31, 2026, from $1,612,372 as of December 31, 2025.
  • Total stockholders' deficit was ($1,245,518) as of March 31, 2026, compared to ($1,222,329) as of December 31, 2025.